Dalrada Financial Corp

PINK:DFCO USA Pharmaceutical Retailers
Market Cap
$1.68 Million
Market Cap Rank
#34945 Global
#11394 in USA
Share Price
$0.01
Change (1 day)
+0.00%
52-Week Range
$0.01 - $0.01
All Time High
$0.91
About

Dalrada Financial Corporation, together with its subsidiaries, provides solutions that directly address climate change, gaps in the health care industry, and technology needs in the United States, Scotland, Spain, and India. It operates through: Genefic, Dalrada Climate Technology, Dalrada Precision Manufacturing, and Dalrada Technologies divisions. The Genefic division provides care and managing… Read more

Dalrada Financial Corp (DFCO) - Net Assets

Latest net assets as of September 2025: $-12.60 Million USD

Based on the latest financial reports, Dalrada Financial Corp (DFCO) has net assets worth $-12.60 Million USD as of September 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($17.98 Million) and total liabilities ($30.58 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets $-12.60 Million
% of Total Assets -70.05%
Annual Growth Rate N/A
5-Year Change N/A
10-Year Change N/A
Growth Volatility 658.68

Dalrada Financial Corp - Net Assets Trend (1986–2025)

This chart illustrates how Dalrada Financial Corp's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Dalrada Financial Corp (1986–2025)

The table below shows the annual net assets of Dalrada Financial Corp from 1986 to 2025.

Year Net Assets Change
2025-06-30 $-6.69 Million -299.89%
2024-06-30 $3.35 Million -21.32%
2023-06-30 $4.25 Million +128.44%
2022-06-30 $-14.95 Million -11.53%
2021-06-30 $-13.41 Million +11.43%
2020-06-30 $-15.14 Million -11.02%
2019-06-30 $-13.64 Million +2.88%
2018-06-30 $-14.04 Million -61.86%
2011-06-30 $-8.67 Million +6.75%
2010-06-30 $-9.30 Million +39.82%
2009-06-30 $-15.46 Million +26.68%
2008-06-30 $-21.08 Million +2.48%
2006-06-30 $-21.62 Million +12.45%
2005-06-30 $-24.70 Million -18.02%
2004-06-30 $-20.93 Million +12.74%
2003-06-30 $-23.98 Million -17.39%
2002-06-30 $-20.43 Million -26.80%
2001-06-30 $-16.11 Million -16.31%
2000-06-30 $-13.85 Million -11.70%
1999-06-30 $-12.40 Million -369.57%
1998-06-30 $4.60 Million -45.88%
1997-06-30 $8.50 Million +93.18%
1996-06-30 $4.40 Million +291.30%
1995-06-30 $-2.30 Million -2400.00%
1994-06-30 $100.00K -97.87%
1993-06-30 $4.70 Million +23.68%
1992-06-30 $3.80 Million +311.11%
1991-06-30 $-1.80 Million -166.67%
1990-06-30 $2.70 Million +268.75%
1989-06-30 $-1.60 Million -135.56%
1988-06-30 $4.50 Million -4.26%
1987-06-30 $4.70 Million +176.47%
1986-06-30 $1.70 Million --

Equity Component Analysis

This analysis shows how different components contribute to Dalrada Financial Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 19232364700.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (June 2025)

Component Amount Percentage
Common Stock $600.78K %
Other Comprehensive Income $11.72 Million %
Other Components $176.25 Million %
Total Equity $-6.75 Million 100.00%

Dalrada Financial Corp Competitors by Market Cap

The table below lists competitors of Dalrada Financial Corp ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Dalrada Financial Corp's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 3,440,131 to -6,753,909, a change of -10,194,040 (-296.3%).
  • Net loss of 24,646,581 reduced equity.
  • Other comprehensive income increased equity by 11,718,307.
  • Other factors increased equity by 2,734,234.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income $-24.65 Million -364.92%
Other Comprehensive Income $11.72 Million +173.5%
Other Changes $2.73 Million +40.48%
Total Change $- -296.33%

Book Value vs Market Value Analysis

This analysis compares Dalrada Financial Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
1986-06-30 $-70.00 $0.01 x
1987-06-30 $-490.02 $0.01 x
1988-06-30 $-455.02 $0.01 x
1989-06-30 $-560.03 $0.01 x
1990-06-30 $-490.02 $0.01 x
1991-06-30 $-630.03 $0.01 x
1992-06-30 $1330.07 $0.01 x
1993-06-30 $1645.08 $0.01 x
1994-06-30 $35.00 $0.01 x
1995-06-30 $-805.04 $0.01 x
1996-06-30 $1540.08 $0.01 x
1997-06-30 $2913.95 $0.01 x
1998-06-30 $1623.72 $0.01 x
1999-06-30 $-3201.65 $0.01 x
2000-06-30 $-531.73 $0.01 x
2001-06-30 $-490.08 $0.01 x
2002-06-30 $-334.84 $0.01 x
2003-06-30 $-51.71 $0.01 x
2004-06-30 $-12.64 $0.01 x
2005-06-30 $-7.50 $0.01 x
2006-06-30 $-1.12 $0.01 x
2018-06-30 $-0.30 $0.01 x
2019-06-30 $-0.21 $0.01 x
2020-06-30 $-0.27 $0.01 x
2021-06-30 $-0.10 $0.01 x
2022-06-30 $-0.21 $0.01 x
2023-06-30 $0.05 $0.01 x
2024-06-30 $0.04 $0.01 x
2025-06-30 $-0.06 $0.01 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Dalrada Financial Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 0.00%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -121.39%
  • • Asset Turnover: 1.11x
  • • Equity Multiplier: 0.00x
  • Recent ROE (0.00%) is above the historical average (-170.06%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
1986 0.00% -55.56% 0.58x 0.00x $-980.00K
1987 0.00% -19.05% 0.81x 0.00x $-660.00K
1988 0.00% -4.30% 1.58x 0.00x $-270.00K
1989 0.00% -9.47% 0.95x 0.00x $-740.00K
1990 0.00% -8.57% 1.12x 0.00x $-760.00K
1991 0.00% -75.00% 1.41x 0.00x $-5.22 Million
1992 2.63% 0.97% 1.87x 1.45x $-280.00K
1993 14.89% 6.86% 1.21x 1.79x $230.00K
1994 -4000.00% -36.04% 1.95x 57.00x $-4.01 Million
1995 0.00% -14.58% 3.43x 0.00x $-1.87 Million
1996 -81.82% -31.03% 1.71x 1.55x $-4.04 Million
1997 9.41% 2.61% 2.22x 1.62x $-50.00K
1998 -221.74% -29.65% 1.64x 4.57x $-10.66 Million
1999 0.00% -145.09% 2.37x 0.00x $-23.86 Million
2000 0.00% -557.44% 1.51x 0.00x $-12.81 Million
2001 0.00% -286.44% 2.85x 0.00x $-8.28 Million
2002 0.00% -54.20% 21.40x 0.00x $-11.65 Million
2003 0.00% -163.60% 0.55x 0.00x $-4.36 Million
2004 0.00% 0.75% 4.74x 0.00x $2.19 Million
2005 0.00% -21.66% 2.90x 0.00x $-1.75 Million
2006 0.00% 3.73% 4.79x 0.00x $4.79 Million
2008 0.00% 95.24% 9.52x 0.00x $11.51 Million
2009 0.00% 2074.03% 0.38x 0.00x $5.30 Million
2010 0.00% 708.17% 1.47x 0.00x $7.08 Million
2011 0.00% 36.01% 2.77x 0.00x $1.50 Million
2018 0.00% 0.00% 0.00x 0.00x $366.79K
2019 0.00% 507.03% 1.36x 0.00x $1.73 Million
2020 0.00% -210.29% 0.42x 0.00x $-958.53K
2021 0.00% 2.68% 0.72x 0.00x $1.43 Million
2022 0.00% -73.17% 0.86x 0.00x $-12.56 Million
2023 -493.85% -68.24% 1.18x 6.13x $-20.70 Million
2024 -841.48% -145.89% 0.86x 6.70x $-29.29 Million
2025 0.00% -121.39% 1.11x 0.00x $-23.97 Million

Industry Comparison

This section compares Dalrada Financial Corp's net assets metrics with peer companies in the Pharmaceutical Retailers industry.

Industry Context

  • Industry: Pharmaceutical Retailers
  • Average net assets among peers: $265,286,733
  • Average return on equity (ROE) among peers: 1.99%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Dalrada Financial Corp (DFCO) $-12.60 Million 0.00% N/A $1.57 Million
Alibaba Health Information Technology Limited (ALBBY) $1.12 Billion -18.54% 0.50x $12.50 Billion
Allstar Health Brands Inc (ALST) $-9.92 Million 0.00% 0.00x $3.83
Bimi International Medical Inc (BIMI) $-409.66K 0.00% 0.00x $296.83
Blum Holdings Inc (BLMH) $-4.74 Million 0.00% 0.00x $8.97 Million
China Jo-Jo Drugstores Inc (CJJD) $26.66 Million -21.17% 1.52x $5.94 Million
Clicks Group Ltd (CLCGY) $1.13 Billion 41.98% 2.72x $4.80 Billion
China BCT Pharmacy Group Inc (CNBI) $134.27 Million 15.68% 0.82x $0.96
Health Advance Inc (HADV) $-105.34K 0.00% 0.00x $25.40K
Healthwarehouse.Com (HEWA) $-3.10 Million 0.00% 0.00x $720.96